2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine

C155H287BrCl3N29O12 — CID 161112990

IUPAC2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine
SMILESC1=CCNC1.C1CCN(C2CCNCC2)C1.C1CN[C@H](CN2CCCC2)C1.CC(=O)C1(c2ccccc2)CCNCC1.CC(Cl)(Cl)CCN.CC(OC(C)(C)C)[C@H](N)C(=O)OC(C)(C)C.CCC(C)[C@H](N)C(=O)OC(C)(C)C.CCCCNCC.CCNC.CCNCC.CNC.CNCC/C=C/Br.CNCC1OCCO1.COCCN.Clc1ccccc1N1CCNCC1.NCC(N)=O.NCC1CCCCC1.NC[C@H]1CCCO1.NC[C@H]1CCCO1.c1ccc(CCNCc2ccccc2)cc1.c1ccc(CNCc2ccccc2)cc1.c1cnc(N2CCNCC2)nc1
InChIInChI=1S/C15H17N.C14H15N.C13H17NO.C12H25NO3.C10H13ClN2.C10H21NO2.2C9H18N2.C8H12N4.C7H15N.C6H15N.C5H10BrN.C5H11NO2.2C5H11NO.C4H9Cl2N.C4H7N.C4H11N.C3H9NO.C3H9N.C2H6N2O.C2H7N/c1-3-7-14(8-4-1)11-12-16-13-15-9-5-2-6-10-15;1-3-7-13(8-4-1)11-15-12-14-9-5-2-6-10-14;1-11(15)13(7-9-14-10-8-13)12-5-3-2-4-6-12;1-8(15-11(2,3)4)9(13)10(14)16-12(5,6)7;11-9-3-1-2-4-10(9)13-7-5-12-6-8-13;1-6-7(2)8(11)9(12)13-10(3,4)5;1-2-8-11(7-1)9-3-5-10-6-4-9;1-2-7-11(6-1)8-9-4-3-5-10-9;1-2-10-8(11-3-1)12-6-4-9-5-7-12;8-6-7-4-2-1-3-5-7;1-3-5-6-7-4-2;1-7-5-3-2-4-6;1-6-4-5-7-2-3-8-5;2*6-4-5-2-1-3-7-5;1-4(5,6)2-3-7;1-2-4-5-3-1;1-3-5-4-2;1-5-3-2-4;1-3-4-2;3-1-2(4)5;1-3-2/h1-10,16H,11-13H2;1-10,15H,11-12H2;2-6,14H,7-10H2,1H3;8-9H,13H2,1-7H3;1-4,12H,5-8H2;7-8H,6,11H2,1-5H3;2*9-10H,1-8H2;1-3,9H,4-7H2;7H,1-6,8H2;7H,3-6H2,1-2H3;2,4,7H,3,5H2,1H3;5-6H,2-4H2,1H3;2*5H,1-4,6H2;2-3,7H2,1H3;1-2,5H,3-4H2;5H,3-4H2,1-2H3;2-4H2,1H3;4H,3H2,1-2H3;1,3H2,(H2,4,5);3H,1-2H3/b;;;;;;;;;;;4-2+;;;;;;;;;;/t;;;8?,9-;;7?,8-;;9-;;;;;;2*5-;;;;;;;/m...0.0.0.....11......./s1
InChIKeyUJYFKDOBNGDHLS-JDERGKDLSA-N
MW2935.45 g/mol
LogP19.38
Rot. Bonds42

About 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine

2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine (PubChem CID 161112990) has the molecular formula C155H287BrCl3N29O12 and a molecular weight of 2935.45 g/mol. Its IUPAC name is 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine.

Molecular Properties

Compound Name2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine
PubChem CID161112990
Molecular FormulaC155H287BrCl3N29O12
Molecular Weight2935.45 g/mol
Exact Mass2931.10
IUPAC Name2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine
SMILESC1=CCNC1.C1CCN(C2CCNCC2)C1.C1CN[C@H](CN2CCCC2)C1.CC(=O)C1(c2ccccc2)CCNCC1.CC(Cl)(Cl)CCN.CC(OC(C)(C)C)[C@H](N)C(=O)OC(C)(C)C.CCC(C)[C@H](N)C(=O)OC(C)(C)C.CCCCNCC.CCNC.CCNCC.CNC.CNCC/C=C/Br.CNCC1OCCO1.COCCN.Clc1ccccc1N1CCNCC1.NCC(N)=O.NCC1CCCCC1.NC[C@H]1CCCO1.NC[C@H]1CCCO1.c1ccc(CCNCc2ccccc2)cc1.c1ccc(CNCc2ccccc2)cc1.c1cnc(N2CCNCC2)nc1
InChIInChI=1S/C15H17N.C14H15N.C13H17NO.C12H25NO3.C10H13ClN2.C10H21NO2.2C9H18N2.C8H12N4.C7H15N.C6H15N.C5H10BrN.C5H11NO2.2C5H11NO.C4H9Cl2N.C4H7N.C4H11N.C3H9NO.C3H9N.C2H6N2O.C2H7N/c1-3-7-14(8-4-1)11-12-16-13-15-9-5-2-6-10-15;1-3-7-13(8-4-1)11-15-12-14-9-5-2-6-10-14;1-11(15)13(7-9-14-10-8-13)12-5-3-2-4-6-12;1-8(15-11(2,3)4)9(13)10(14)16-12(5,6)7;11-9-3-1-2-4-10(9)13-7-5-12-6-8-13;1-6-7(2)8(11)9(12)13-10(3,4)5;1-2-8-11(7-1)9-3-5-10-6-4-9;1-2-7-11(6-1)8-9-4-3-5-10-9;1-2-10-8(11-3-1)12-6-4-9-5-7-12;8-6-7-4-2-1-3-5-7;1-3-5-6-7-4-2;1-7-5-3-2-4-6;1-6-4-5-7-2-3-8-5;2*6-4-5-2-1-3-7-5;1-4(5,6)2-3-7;1-2-4-5-3-1;1-3-5-4-2;1-5-3-2-4;1-3-4-2;3-1-2(4)5;1-3-2/h1-10,16H,11-13H2;1-10,15H,11-12H2;2-6,14H,7-10H2,1H3;8-9H,13H2,1-7H3;1-4,12H,5-8H2;7-8H,6,11H2,1-5H3;2*9-10H,1-8H2;1-3,9H,4-7H2;7H,1-6,8H2;7H,3-6H2,1-2H3;2,4,7H,3,5H2,1H3;5-6H,2-4H2,1H3;2*5H,1-4,6H2;2-3,7H2,1H3;1-2,5H,3-4H2;5H,3-4H2,1-2H3;2-4H2,1H3;4H,3H2,1-2H3;1,3H2,(H2,4,5);3H,1-2H3/b;;;;;;;;;;;4-2+;;;;;;;;;;/t;;;8?,9-;;7?,8-;;9-;;;;;;2*5-;;;;;;;/m...0.0.0.....11......./s1
InChIKeyUJYFKDOBNGDHLS-JDERGKDLSA-N
XLogP19.38
TPSA583.46 Ų
H-Bond Donors23
H-Bond Acceptors40
Rotatable Bonds42
Heavy Atoms200
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002935.45
LogP ≤ 519.38
H-Bond Donors ≤ 523
H-Bond Acceptors ≤ 1040

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine?
The IUPAC name of 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine (CID 161112990) is 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine.
What is the SMILES notation for 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine?
The canonical SMILES for 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine is C1=CCNC1.C1CCN(C2CCNCC2)C1.C1CN[C@H](CN2CCCC2)C1.CC(=O)C1(c2ccccc2)CCNCC1.CC(Cl)(Cl)CCN.CC(OC(C)(C)C)[C@H](N)C(=O)OC(C)(C)C.CCC(C)[C@H](N)C(=O)OC(C)(C)C.CCCCNCC.CCNC.CCNCC.CNC.CNCC/C=C/Br.CNCC1OCCO1.COCCN.Clc1ccccc1N1CCNCC1.NCC(N)=O.NCC1CCCCC1.NC[C@H]1CCCO1.NC[C@H]1CCCO1.c1ccc(CCNCc2ccccc2)cc1.c1ccc(CNCc2ccccc2)cc1.c1cnc(N2CCNCC2)nc1.
What is the InChIKey of 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine?
The InChIKey is UJYFKDOBNGDHLS-JDERGKDLSA-N. The full InChI is InChI=1S/C15H17N.C14H15N.C13H17NO.C12H25NO3.C10H13ClN2.C10H21NO2.2C9H18N2.C8H12N4.C7H15N.C6H15N.C5H10BrN.C5H11NO2.2C5H11NO.C4H9Cl2N.C4H7N.C4H11N.C3H9NO.C3H9N.C2H6N2O.C2H7N/c1-3-7-14(8-4-1)11-12-16-13-15-9-5-2-6-10-15;1-3-7-13(8-4-1)11-15-12-14-9-5-2-6-10-14;1-11(15)13(7-9-14-10-8-13)12-5-3-2-4-6-12;1-8(15-11(2,3)4)9(13)10(14)16-12(5,6)7;11-9-3-1-2-4-10(9)13-7-5-12-6-8-13;1-6-7(2)8(11)9(12)13-10(3,4)5;1-2-8-11(7-1)9-3-5-10-6-4-9;1-2-7-11(6-1)8-9-4-3-5-10-9;1-2-10-8(11-3-1)12-6-4-9-5-7-12;8-6-7-4-2-1-3-5-7;1-3-5-6-7-4-2;1-7-5-3-2-4-6;1-6-4-5-7-2-3-8-5;2*6-4-5-2-1-3-7-5;1-4(5,6)2-3-7;1-2-4-5-3-1;1-3-5-4-2;1-5-3-2-4;1-3-4-2;3-1-2(4)5;1-3-2/h1-10,16H,11-13H2;1-10,15H,11-12H2;2-6,14H,7-10H2,1H3;8-9H,13H2,1-7H3;1-4,12H,5-8H2;7-8H,6,11H2,1-5H3;2*9-10H,1-8H2;1-3,9H,4-7H2;7H,1-6,8H2;7H,3-6H2,1-2H3;2,4,7H,3,5H2,1H3;5-6H,2-4H2,1H3;2*5H,1-4,6H2;2-3,7H2,1H3;1-2,5H,3-4H2;5H,3-4H2,1-2H3;2-4H2,1H3;4H,3H2,1-2H3;1,3H2,(H2,4,5);3H,1-2H3/b;;;;;;;;;;;4-2+;;;;;;;;;;/t;;;8?,9-;;7?,8-;;9-;;;;;;2*5-;;;;;;;/m...0.0.0.....11......./s1.
What are the key properties of 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine?
2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine has a molecular weight of 2935.45 g/mol, XLogP of 19.38, 42 rotatable bonds, 23 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 2-aminoacetamide;N-benzyl-2-phenylethanamine;N-benzyl-1-phenylmethanamine;(E)-4-bromo-N-methylbut-3-en-1-amine;tert-butyl (2S)-2-amino-3-methylpentanoate;tert-butyl (2S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;1-(2-chlorophenyl)piperazine;cyclohexylmethanamine;3,3-dichlorobutan-1-amine;2,5-dihydro-1H-pyrrole;1-(1,3-dioxolan-2-yl)-N-methylmethanamine;N-ethylbutan-1-amine;N-ethylethanamine;2-methoxyethanamine;N-methylethanamine;N-methylmethanamine;bis([(2R)-oxolan-2-yl]methanamine);1-(4-phenylpiperidin-4-yl)ethanone;2-piperazin-1-ylpyrimidine;1-[[(2S)-pyrrolidin-2-yl]methyl]pyrrolidine;4-pyrrolidin-1-ylpiperidine is sourced from PubChem (CID 161112990), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).